Growth Metrics

Lexicon Pharmaceuticals (LXRX) Interest & Investment Income: 2009-2011

Historic Interest & Investment Income for Lexicon Pharmaceuticals (LXRX) over the last 3 years, with Dec 2011 value amounting to $40,000.

  • Lexicon Pharmaceuticals' Interest & Investment Income fell 21.57% to $40,000 in Q4 2011 from the same period last year, while for Dec 2011 it was $255,000, marking a year-over-year decrease of 50.87%. This contributed to the annual value of $255,000 for FY2011, which is 50.87% down from last year.
  • Per Lexicon Pharmaceuticals' latest filing, its Interest & Investment Income stood at $40,000 for Q4 2011, which was down 33.33% from $60,000 recorded in Q3 2011.
  • Lexicon Pharmaceuticals' Interest & Investment Income's 5-year high stood at $327,000 during Q1 2009, with a 5-year trough of $40,000 in Q4 2011.
  • Over the past 3 years, Lexicon Pharmaceuticals' median Interest & Investment Income value was $87,000 (recorded in 2011), while the average stood at $131,182.
  • As far as peak fluctuations go, Lexicon Pharmaceuticals' Interest & Investment Income plummeted by 78.66% in 2010, and later increased by 17.65% in 2011.
  • Over the past 3 years, Lexicon Pharmaceuticals' Interest & Investment Income (Quarterly) stood at $239,000 in 2009, then slumped by 78.66% to $51,000 in 2010, then declined by 21.57% to $40,000 in 2011.
  • Its Interest & Investment Income was $40,000 in Q4 2011, compared to $60,000 in Q3 2011 and $68,000 in Q2 2011.